21 / 38
Immunotherapy in
EGFR
-mutant
Lee – J Thorac Oncol 2017 * Dong – OncoImmunology 2017
In
EGFR
-mutant, immune checkpoint inhibitors do not improve OS over CT
N=1362
N=186
P<0.0001
P<0.081
CheckMate 722
(NCT02864251) phase III: Nivo + CT
vs
. Nivo + Ipi
vs
. CT in
T790M
-negative